The Evolving Role of Radiotherapy in Early Stage Hodgkin's Lymphoma. - Wikidata - wikimedia - TriplyDB

The Evolving Role of Radiotherapy in Early Stage Hodgkin's Lymphoma.

The Evolving Role of Radiotherapy in Early Stage Hodgkin's Lymphoma.

http://www.wikidata.org/entity/Q33778385

about

Chemotherapy alone or combined chemotherapy and involved field radiotherapy in favorable risk early-stage classical Hodgkin lymphoma-a 10 years experience.Optimal Therapy for Early-Stage Hodgkin's Lymphoma: Risk Adapting, Response Adapting, and Role of Radiotherapy.

P2860

Q37563122-B78B74FA-564E-4106-A8B3-52767EDF3842 Q39213429-A80F4B4A-8110-45AB-B20A-9D0D3A9ACC67

P2860

The Evolving Role of Radiotherapy in Early Stage Hodgkin's Lymphoma.

http://www.wikidata.org/entity/Q33778385

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

The Evolving Role of Radiotherapy in Early Stage Hodgkin's Lymphoma.

@ast

The Evolving Role of Radiotherapy in Early Stage Hodgkin's Lymphoma.

@en

type

label

The Evolving Role of Radiotherapy in Early Stage Hodgkin's Lymphoma.

@ast

The Evolving Role of Radiotherapy in Early Stage Hodgkin's Lymphoma.

@en

prefLabel

The Evolving Role of Radiotherapy in Early Stage Hodgkin's Lymphoma.

@ast

The Evolving Role of Radiotherapy in Early Stage Hodgkin's Lymphoma.

@en

P1433

Q33778385-DCAC902D-4270-4F16-9834-6CF9614E7240

P1476

Q33778385-0A450F93-7D16-4598-8048-838E523C728E

P2093

Q33778385-3815FB39-961B-4368-A48D-85AA4BA60FF4

Q33778385-8AA639F0-9D6E-406D-9E50-947F3136302E

P2860

Q33778385-01A1622C-38BF-4D54-A911-92E508A8B5C5

Q33778385-10A07DA9-4FB2-4D9F-8616-D823257ACDD1

Q33778385-1391421F-6AE7-497B-AC3C-26AF9A21A5D2

Q33778385-2D2B9678-FADF-4198-991A-DD78A95CF559

Q33778385-3B7B8FF2-A256-4A95-BCD1-E85F04206A20

Q33778385-41AA292A-2492-4EC1-B6E2-61D3366FE1AE

Q33778385-43758C13-36B0-4FEA-B449-974262828778

Q33778385-47555E7C-5958-4256-AD4D-259381A11E07

Q33778385-5DC55028-C445-4875-8DF9-B27C88980718

Q33778385-657C6AD9-6F98-47AB-A96A-6F541F5548DC

P304

Q33778385-DB2A4BC8-0065-460C-8A29-3A751BD940E6

P31

Q33778385-80229F0E-4900-4FD9-93A3-1FE0B6EB0F4A

P356

Q33778385-F85FEEE1-2084-41CC-BB9D-4DF69853EF9A

P433

Q33778385-25AF48BE-30BE-4671-8705-FA842686FEE2

P478

Q33778385-2ADA25BA-C0D5-4D31-8E84-747BF66993F8

P50

Q33778385-6656541D-F3FA-4A21-8DAC-F1A37246D44B

Q33778385-AE3A4E5F-B87A-4AE2-B5E1-1D4A4DEE1A7D

P577

Q33778385-4BD62319-A8AB-49F7-BEBA-E885ABE11338

P698

Q33778385-1C297D50-4CD9-4EC4-B110-FAA0A2AE768D

P932

Q33778385-0B97DE17-6261-4CB0-9318-DE8E0E0FA36B

P356

P1433

Mediterranean journal of hematology and infectious diseases

P1476

The Evolving Role of Radiotherapy in Early Stage Hodgkin's Lymphoma

@en

P2093

Cristina Piva

http://www.w3.org/2001/XMLSchema#string

Umberto Ricardi

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapy, radiotherapy and combined modality for Hodgkin's disease, with emphasis on second cancer risk

Combined modality treatment improves tumor control and overall survival in patients with early stage Hodgkin's lymphoma: a systematic review.

Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's

ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term results.

Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial.

Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial.

Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.

The involved field is back: issues in delineating the radiation field in Hodgkin's disease.

Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.

Long-term results of CCG 5942: a randomized comparison of chemotherapy with and without radiotherapy for children with Hodgkin's lymphoma--a report from the Children's Oncology Group

P304

e2014035

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4084/MJHID.2014.035

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Andrea Riccardo Filippi

Pierfrancesco Franco

P577

2014-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24959332

http://www.w3.org/2001/XMLSchema#string

P932

4063609

http://www.w3.org/2001/XMLSchema#string